1. Home
  2. ABP vs NCRA Comparison

ABP vs NCRA Comparison

Compare ABP & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • NCRA
  • Stock Information
  • Founded
  • ABP 2004
  • NCRA 2002
  • Country
  • ABP United States
  • NCRA Taiwan
  • Employees
  • ABP N/A
  • NCRA 22
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • NCRA Farming/Seeds/Milling
  • Sector
  • ABP Health Care
  • NCRA Consumer Staples
  • Exchange
  • ABP Nasdaq
  • NCRA Nasdaq
  • Market Cap
  • ABP 15.5M
  • NCRA 15.4M
  • IPO Year
  • ABP N/A
  • NCRA N/A
  • Fundamental
  • Price
  • ABP $0.21
  • NCRA $1.02
  • Analyst Decision
  • ABP Strong Buy
  • NCRA
  • Analyst Count
  • ABP 1
  • NCRA 0
  • Target Price
  • ABP $4.00
  • NCRA N/A
  • AVG Volume (30 Days)
  • ABP 28.3M
  • NCRA 132.9K
  • Earning Date
  • ABP 05-15-2025
  • NCRA 05-15-2025
  • Dividend Yield
  • ABP N/A
  • NCRA N/A
  • EPS Growth
  • ABP N/A
  • NCRA N/A
  • EPS
  • ABP N/A
  • NCRA N/A
  • Revenue
  • ABP $183,000.00
  • NCRA $16,647,379.00
  • Revenue This Year
  • ABP N/A
  • NCRA N/A
  • Revenue Next Year
  • ABP N/A
  • NCRA N/A
  • P/E Ratio
  • ABP N/A
  • NCRA N/A
  • Revenue Growth
  • ABP 88.66
  • NCRA N/A
  • 52 Week Low
  • ABP $0.15
  • NCRA $0.70
  • 52 Week High
  • ABP $11.19
  • NCRA $2.09
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • NCRA 50.34
  • Support Level
  • ABP N/A
  • NCRA $0.91
  • Resistance Level
  • ABP N/A
  • NCRA $1.25
  • Average True Range (ATR)
  • ABP 0.00
  • NCRA 0.11
  • MACD
  • ABP 0.00
  • NCRA -0.00
  • Stochastic Oscillator
  • ABP 0.00
  • NCRA 22.29

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: